6533b86efe1ef96bd12cbc6f
RESEARCH PRODUCT
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity
Christiane MaierJosef HoegelMaximilian KlarManuel LuedekeMeta VolcicAnnette HasenburgAnnette HasenburgAntje E. RincklebLisa WiesmüllerBarbara BurwinkelBarbara BurwinkelWalther VogelHelmut DeisslerHarald SurowyFrederik MarméChristof SohnDominic Vargasubject
0301 basic medicineGeneticsCancer ResearchCandidate geneHaplotypeLocus (genetics)Single-nucleotide polymorphismBiologyPenetrance03 medical and health sciences030104 developmental biologyOncologyAlleleAllele frequencyImputation (genetics)description
Only a fraction of breast cancer (BC) cases can be yet explained by mutations in genes or genomic variants discovered in linkage, genome-wide association and sequencing studies. The known genes entailing medium or high risk for BC are strongly enriched for a function in DNA double strand repair. Thus, aiming at identifying low frequency variants conferring an intermediate risk, we here investigated 17 variants (MAF: 0.01-0.1) in 10 candidate genes involved in DNA repair or cell cycle control. In an exploration cohort of 437 cases and 1189 controls, we show the variant rs3810813 in the SLX4/FANCP gene to be significantly associated with both BC (≤60 years; OR = 2.6(1.6-3.9), p = 1.6E-05) and decreased DNA repair capacity (≤60 years; beta = 37.8(17.9-57.8), p = 5.3E-4). BC association was confirmed in a verification cohort (N = 2441). Both associations were absent from cases diagnosed >60 years and stronger the earlier the diagnosis. By imputation we show that rs3810813 tags a haplotype with 5 additional variants with the same allele frequency (R2 > 0.9), and a pattern of association very similar for both phenotypes (cases 0.9). Our findings propose a risk variant with high penetrance on the haplotype spanning SLX4/FANCP to be functionally associated to BC predisposition via decreased repair capacity and suggest this variant is carried by a fraction of these haplotypes that is enriched in early onset BC cases.
year | journal | country | edition | language |
---|---|---|---|---|
2017-10-30 | International Journal of Cancer |